US Bancorp’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2 | Hold |
1
| – | – | ﹤0.01% | 4141 |
|
|
2025
Q1 | $2 | Sell |
1
-1
| -50% | -$2 | ﹤0.01% | 4162 |
|
|
2024
Q4 | $12 | Sell |
2
-1,125
| -100% | -$6.75K | ﹤0.01% | 4133 |
|
|
2024
Q3 | $11K | Sell |
1,127
-27
| -2% | -$264 | ﹤0.01% | 3333 |
|
|
2024
Q2 | $23.6K | Buy |
1,154
+27
| +2% | +$553 | ﹤0.01% | 2986 |
|
|
2024
Q1 | $50.9K | Hold |
1,127
| – | – | ﹤0.01% | 2679 |
|
|
2023
Q4 | $53.2K | Hold |
1,127
| – | – | ﹤0.01% | 2646 |
|
|
2023
Q3 | $45.6K | Buy |
1,127
+247
| +28% | +$10K | ﹤0.01% | 2490 |
|
|
2023
Q2 | $93.7K | Buy |
880
+878
| +43,900% | +$93.5K | ﹤0.01% | 2207 |
|
|
2023
Q1 | $616 | Hold |
2
| – | – | ﹤0.01% | 3905 |
|
|
2022
Q4 | $709 | Sell |
2
-24
| -92% | -$8.51K | ﹤0.01% | 3939 |
|
|
2022
Q3 | $5K | Sell |
26
-12
| -32% | -$2.31K | ﹤0.01% | 3553 |
|
|
2022
Q2 | $8K | Sell |
38
-7
| -16% | -$1.47K | ﹤0.01% | 3396 |
|
|
2022
Q1 | $15K | Sell |
45
-7
| -13% | -$2.33K | ﹤0.01% | 3198 |
|
|
2021
Q4 | $17K | Sell |
52
-14
| -21% | -$4.58K | ﹤0.01% | 3175 |
|
|
2021
Q3 | $32K | Sell |
66
-21
| -24% | -$10.2K | ﹤0.01% | 2863 |
|
|
2021
Q2 | $41K | Sell |
87
-220
| -72% | -$104K | ﹤0.01% | 2757 |
|
|
2021
Q1 | $212K | Sell |
307
-16
| -5% | -$11K | ﹤0.01% | 1897 |
|
|
2020
Q4 | $238K | Buy |
323
+24
| +8% | +$17.7K | ﹤0.01% | 1797 |
|
|
2020
Q3 | $207K | Buy |
299
+153
| +105% | +$106K | ﹤0.01% | 1748 |
|
|
2020
Q2 | $124K | Sell |
146
-43
| -23% | -$36.5K | ﹤0.01% | 1977 |
|
|
2020
Q1 | $68K | Buy |
+189
| New | +$68K | ﹤0.01% | 2158 |
|